In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine
Abstract Human papillomavirus (HPV) is the most common sexually transmitted infection in the world and the main cause of cervical cancer. Nowadays, the virus-like particles (VLPs) based on L1 proteins have been considered as the best candidate for vaccine development against HPV infections. Two comm...
Guardado en:
Autores principales: | Ali Namvar, Azam Bolhassani, Gholamreza Javadi, Zahra Noormohammadi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2e7fcb93524c4160ad6bfc052b0c8016 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Synergistic effects of exosomal crocin or curcumin compounds and HPV L1-E7 polypeptide vaccine construct on tumor eradication in C57BL/6 mouse model.
por: Elnaz Abbasifarid, et al.
Publicado: (2021) -
Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis.
por: Noushin Saljoughian, et al.
Publicado: (2013) -
Bauhinia acuminata L. attenuates lung cancer cell proliferation: in vitro, in vivo and in silico approaches
por: Divya Sebastian, et al.
Publicado: (2022) -
Species relationship and genetic diversity in some Iranian Lamium L. species using ISSR markers
por: FATEMEH AZIMISHAD, et al.
Publicado: (2019) -
Human papillomavirus vaccination: evidence base for efficacy and safety
por: Yuliya E. Dobrokhotova, et al.
Publicado: (2021)